$4208 | SAVE $742 | Single User
$5313 | SAVE $937 | Enterprise License

Global Subcutaneous Drug Delivery Devices Market Size study, by Product, by Distribution Channel and Regional Forecasts 2020-2027

Global Subcutaneous Drug Delivery Devices Market Size study, by Product (Prefilled Syringes, Pen Injectors, Auto Injectors, Wearable Injectors, Needle-Free Injectors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027
[Lowest Price Guaranteed: $4,208]

Published by Bizwit Research and Consulting: 20 Oct 2020 | 280172 | In Stock
Related Topics: Delivery , Drug , Drug Delivery , Investment , Medical , Retail , Services

Introduction

Global Subcutaneous Drug Delivery Devices Market is valued approximately at USD 9.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2020-2027. Subcutaneous drugs are vaccinated in the layer of the skin called the cutis, which includes dermis and epidermis. The subcutaneous parenteral route of drug delivery is operative for managing vaccines and for continual release drugs and for goserelin, insulin, etc. The subcutaneous drug delivery systems are generally utilized by the end-users owing to the easy and consistent operating mechanism. Several pharmaceutical products are promoted and being established for numerous diseases, which are managed through subcutaneous routes. Drug manufactures are also emphasizing on easy administration process of drug delivery, so as the drug can be extremely effective among the patients. Many pharmaceutical companies are evolving and developing self-managed drugs, the adoption rate of subcutaneous drug delivery devices has grown across the globe. Moreover, the rise in prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer etc., growing production of biologics, and rising emphasis on self-administration, prevention of needlestick injuries and dosing errors are the few factors responsible for the high CAGR of the market during the forecast period. According to the American Heart Association, cardiovascular diseases (CVD) is the leading cause of mortality and morbidity around the world. There were around 17.6 million deaths due to CVD reported in 2016, which is projected to reach almost 23.6 million by the year 2030. While as per the International Diabetic Federation (IDF), there were almost 463 million adults aged between 20-79 years are affected with diabetes in 2019, and this estimation is anticipated to reach at almost 700 million by the year 2045. This, in turn, is likely to strengthen the demand for subcutaneous drug delivery devices, thus accelerating the market growth around the world. However, the high cost of advanced delivery systems and lack of awareness about these devices are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Subcutaneous Drug Delivery Devices market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in prevalence of cancer and cardiovascular diseases, along with the presence of substantial number of suppliers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of diabetic and multiple sclerosis patients coupled with improving healthcare infrastructure in the developing nations, such as China and India, would create lucrative growth prospects for the Subcutaneous Drug Delivery Devices market across the Asia-Pacific region.

Major market player included in this report are:

Gerresheimer AG

Medtronic plc

Ypsomed AG

Elcam Medical Group

Novo Nordisk A/S

Insulet Corporation

Becton, Dickinson, and Company

West Pharmaceutical Services, Inc.

PharmaJet, Inc.

Unilife Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Prefilled Syringes

Pen Injectors

Auto Injectors

Wearable Injectors

Needle-Free Injectors

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Subcutaneous Drug Delivery Devices Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents
for Global Subcutaneous Drug Delivery Devices Market Size study, by Product (Prefilled Syringes, Pen Injectors, Auto Injectors, Wearable Injectors, Needle-Free Injectors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027

  • Chapter 1. Executive Summary

    1.1. Market Snapshot

    1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

    1.2.1. Subcutaneous Drug Delivery Devices Market, by Region, 2018-2027 (USD Billion)

    1.2.2. Subcutaneous Drug Delivery Devices Market, by Product, 2018-2027 (USD Billion)

    1.2.3. Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2018-2027 (USD Billion)

    1.3. Key Trends

    1.4. Estimation Methodology

    1.5. Research Assumption

    Chapter 2. Global Subcutaneous Drug Delivery Devices Market Definition and Scope

    2.1. Objective of the Study

    2.2. Market Definition & Scope

    2.2.1. Scope of the Study

    2.2.2. Industry Evolution

    2.3. Years Considered for the Study

    2.4. Currency Conversion Rates

    Chapter 3. Global Subcutaneous Drug Delivery Devices Market Dynamics

    3.1. Subcutaneous Drug Delivery Devices Market Impact Analysis (2018-2027)

    3.1.1. Market Drivers

    3.1.2. Market Challenges

    3.1.3. Market Opportunities

    Chapter 4. Global Subcutaneous Drug Delivery Devices Market Industry Analysis

    4.1. Porter’s 5 Force Model

    4.1.1. Bargaining Power of Suppliers

    4.1.2. Bargaining Power of Buyers

    4.1.3. Threat of New Entrants

    4.1.4. Threat of Substitutes

    4.1.5. Competitive Rivalry

    4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

    4.2. PEST Analysis

    4.2.1. Political

    4.2.2. Economical

    4.2.3. Social

    4.2.4. Technological

    4.3. Investment Adoption Model

    4.4. Analyst Recommendation & Conclusion

    Chapter 5. Global Subcutaneous Drug Delivery Devices Market, by Product

    5.1. Market Snapshot

    5.2. Global Subcutaneous Drug Delivery Devices Market by Product, Performance - Potential Analysis

    5.3. Global Subcutaneous Drug Delivery Devices Market Estimates & Forecasts by Product 2017-2027 (USD Billion)

    5.4. Subcutaneous Drug Delivery Devices Market, Sub Segment Analysis

    5.4.1. Prefilled Syringes

    5.4.2. Pen Injectors

    5.4.3. Auto Injectors

    5.4.4. Wearable Injectors

    5.4.5. Needle-Free Injectors

    Chapter 6. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel

    6.1. Market Snapshot

    6.2. Global Subcutaneous Drug Delivery Devices Market by Distribution Channel, Performance - Potential Analysis

    6.3. Global Subcutaneous Drug Delivery Devices Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)

    6.4. Subcutaneous Drug Delivery Devices Market, Sub Segment Analysis

    6.4.1. Hospital Pharmacies

    6.4.2. Retail Pharmacies

    6.4.3. Online Pharmacies

    Chapter 7. Global Subcutaneous Drug Delivery Devices Market, Regional Analysis

    7.1. Subcutaneous Drug Delivery Devices Market, Regional Market Snapshot

    7.2. North America Subcutaneous Drug Delivery Devices Market

    7.2.1. U.S. Subcutaneous Drug Delivery Devices Market

    7.2.1.1. Product breakdown estimates & forecasts, 2017-2027

    7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027

    7.2.2. Canada Subcutaneous Drug Delivery Devices Market

    7.3. Europe Subcutaneous Drug Delivery Devices Market Snapshot

    7.3.1. U.K. Subcutaneous Drug Delivery Devices Market

    7.3.2. Germany Subcutaneous Drug Delivery Devices Market

    7.3.3. France Subcutaneous Drug Delivery Devices Market

    7.3.4. Spain Subcutaneous Drug Delivery Devices Market

    7.3.5. Italy Subcutaneous Drug Delivery Devices Market

    7.3.6. Rest of Europe Subcutaneous Drug Delivery Devices Market

    7.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market Snapshot

    7.4.1. China Subcutaneous Drug Delivery Devices Market

    7.4.2. India Subcutaneous Drug Delivery Devices Market

    7.4.3. Japan Subcutaneous Drug Delivery Devices Market

    7.4.4. Australia Subcutaneous Drug Delivery Devices Market

    7.4.5. South Korea Subcutaneous Drug Delivery Devices Market

    7.4.6. Rest of Asia Pacific Subcutaneous Drug Delivery Devices Market

    7.5. Latin America Subcutaneous Drug Delivery Devices Market Snapshot

    7.5.1. Brazil Subcutaneous Drug Delivery Devices Market

    7.5.2. Mexico Subcutaneous Drug Delivery Devices Market

    7.6. Rest of The World Subcutaneous Drug Delivery Devices Market

    Chapter 8. Competitive Intelligence

    8.1. Top Market Strategies

    8.2. Company Profiles

    8.2.1. Gerresheimer AG

    8.2.1.1. Key Information

    8.2.1.2. Overview

    8.2.1.3. Financial (Subject to Data Availability)

    8.2.1.4. Product Summary

    8.2.1.5. Recent Developments

    8.2.2. Medtronic plc

    8.2.3. Ypsomed AG

    8.2.4. Elcam Medical Group

    8.2.5. Novo Nordisk A/S

    8.2.6. Insulet Corporation

    8.2.7. Becton, Dickinson, and Company

    8.2.8. West Pharmaceutical Services, Inc.

    8.2.9. PharmaJet, Inc.

    8.2.10. Unilife Corporation

    Chapter 9. Research Process

    9.1. Research Process

    9.1.1. Data Mining

    9.1.2. Analysis

    9.1.3. Market Estimation

    9.1.4. Validation

    9.1.5. Publishing

    9.2. Research Attributes

    9.3. Research Assumption

List Of Tables
in Global Subcutaneous Drug Delivery Devices Market Size study, by Product, by Distribution Channel and Regional Forecasts 2020-2027

TABLE 1. Global Subcutaneous Drug Delivery Devices market, report scope

TABLE 2. Global Subcutaneous Drug Delivery Devices market estimates & forecasts by region 2017-2027 (USD Billion)

TABLE 3. Global Subcutaneous Drug Delivery Devices market estimates & forecasts by Product 2017-2027 (USD Billion)

TABLE 4. Global Subcutaneous Drug Delivery Devices market estimates & forecasts by Distribution Channel 2017-2027 (USD Billion)

TABLE 5. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 6. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 7. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 20. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 21. U.S. Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. U.S. Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 23. U.S. Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 24. Canada Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 25. Canada Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 26. Canada Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 27. UK Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 28. UK Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 29. UK Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 30. Germany Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 31. Germany Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 32. Germany Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 33. France Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 34. France Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 35. France Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 36. Spain Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 37. Spain Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 38. Spain Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 39. Italy Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 40. Italy Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 41. Italy Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 42. ROE Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 43. ROE Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 44. ROE Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 45. China Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 46. China Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 47. China Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 48. India Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 49. India Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 50. India Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 51. Japan Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 52. Japan Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 53. Japan Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 54. Australia Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 55. Australia Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 56. Australia Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 57. South Korea Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 58. South Korea Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 59. South Korea Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 60. ROPAC Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 61. ROPAC Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 62. ROPAC Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 63. Brazil Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 64. Brazil Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 65. Brazil Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 66. Mexico Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 67. Mexico Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 68. Mexico Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 69. ROLA Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 70. ROLA Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 71. ROLA Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 72. ROW Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 73. ROW Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 74. ROW Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 75. List of secondary sources, used in the study of global Subcutaneous Drug Delivery Devices market

TABLE 76. List of primary sources, used in the study of global Subcutaneous Drug Delivery Devices market

TABLE 77. Years considered for the study

TABLE 78. Exchange rates considered

List Of Figures, Charts and Diagrams
in Global Subcutaneous Drug Delivery Devices Market Size study, by Product, by Distribution Channel and Regional Forecasts 2020-2027

FIG 1. Global Subcutaneous Drug Delivery Devices market, research methodology

FIG 2. Global Subcutaneous Drug Delivery Devices market, market estimation techniques

FIG 3. Global market size estimates & forecast methods

FIG 4. Global Subcutaneous Drug Delivery Devices market, key trends 2019

FIG 5. Global Subcutaneous Drug Delivery Devices market, growth prospects 2020-2027

FIG 6. Global Subcutaneous Drug Delivery Devices market, porters 5 force Model

FIG 7. Global Subcutaneous Drug Delivery Devices market, pest analysis

FIG 8. Global Subcutaneous Drug Delivery Devices market, value chain analysis

FIG 9. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 10. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 11. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 12. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 13. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 14. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 15. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 16. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)

FIG 17. Global Subcutaneous Drug Delivery Devices market, regional snapshot 2017 & 2027

FIG 18. North America Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)

FIG 19. Europe Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)

FIG 20. Asia-Pacific Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)

FIG 21. Latin America Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)

FIG 22. Global Subcutaneous Drug Delivery Devices market, company market share analysis (2019)

Additional Details

Publisher

Bizwit Research and Consulting

Publisher Information

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We offer wide range of services including Syndicated Reports, Customized Reports, and Competitive Intelligence and others.

Reference

280172 |

Number of Pages

200

Report Format

PDF

Bizwit Research and Consulting Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Global Subcutaneous Implantable Defibrillators Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Subcutaneous Impla...
29 Jun 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Global Subcutaneous Infusion Systems Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Subcutaneous Infu...
29 Jun 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Global Subcutaneous Implantable Defibrillators Market Research Report Forecast 2017 to 2021
The Global Subcutaneous Implantable Defibrillators Market Research Report Forecast 2017-2021 is a va...
10 May 2017 by S&P Consulting USD $2,380 (normally
USD $2,800)
More Info
SAVE 15% today! Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022
The active implantable medical devices market is estimated to grow at a CAGR of 7.8% from 2017 to 20...
05 Apr 2017 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)] and Geography (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Implantable defibrillators is a battery-powered small device placed underneath chest or abdomen to k...
01 Apr 2017 by Allied Market Research USD $4,565 (normally
USD $5,371)
More Info
SAVE 15% today! Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)] and Geography (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Implantable defibrillators is a battery-powered small device placed underneath chest or abdomen to k...
01 Mar 2017 by Allied Market Research USD $4,565 (normally
USD $5,371)
More Info
SAVE 15% today! Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021
The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 b...
30 Nov 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Vascular Access Devices Market: By Type (Peripheral, PIV Catheters, Others); By Route of Insertion (Subcutaneous, Intravenous); By Application (Medication, Diagnostic Testing, Others); By End User (Hospitals, Clinics, Others) & By Region-Forecast (2016-2022)
Vascular access devices are medical apparatus used to gain access to the blood stream to deliver med...
16 Sep 2016 by USD $5,250 (normally
USD $6,176)
More Info
SAVE 15% today! Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021
The vaccine adjuvants market is expected to reach USD 769.4 million by 2021 from USD 467.0 million i...
15 Jun 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography-Forecast (2016-2021)
Immunoglobulin refers to the breakdown of blood plasma that contains antibody and Intravenous immuno...
26 Feb 2016 by USD $5,250 (normally
USD $6,176)
More Info

This report is published by Bizwit Research and Consulting

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We offer wide range of services including Syndicated Reports, Customized Reports, and Competitive Intelligence and others.

Download Free Report Summary PDF

Global Subcutaneous Drug Delivery Devices Market Size study, by Product (Prefilled Syringes, Pen Injectors, Auto Injectors, Wearable Injectors, Needle-Free Injectors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...